Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two prednisone tapering strategies in generalized autoimmune myasthenia treated with prednisone plus azathioprine
2007-007728-16Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone and azathioprine in myasthenia gravis (MG) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Proportion of improved patients or patients in minimal manifestation status and Faster corticosteroid withdrawal with equivalent efficacy. Started Mar 2009; status: active.
02
Drugs
prednisoneazathioprine
03
Conditions
myasthenia gravis (MG)
Beyond the preview
Go deeper on 2007-007728-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007728-16.